loading...| Preferred Name |
eletriptan |
| Synonyms |
Relpax |
| ID |
http://purl.bioontology.org/ontology/MESH/C115647 |
| altLabel |
Relpax UK-166044 UK-166,044 UK-116,044-04 UK 166044 UK-116044-04 3-(1-methyl-2-pyrrolidinylmethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole hydrobromide UK 166,044 eletriptan hydrobromide (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole (R)-3-((1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole monohydrobromide |
| cui |
C4307738 C0759932 C1178489 C1171655 C0759933 |
| HM |
D011759 D014363 |
| Inverse of RB |
22QOO9B8KI M41W832TA3 0 |
| isa | |
| LT |
TRD |
| Mapped to | |
| MDA |
19981130 |
| MeSH Frequency |
164 |
| MMR |
20161103 |
| notation |
C115647 |
| PA |
D017366 |
| PI |
*INDOLES (1998-2005) |
| prefLabel |
eletriptan |
| RR |
M41W832TA3 |
| SC |
1 |
| Scope Statement |
5-HT(1B/1D) receptor agonist; structure in first source |
| SRC |
Naunyn Schmiedebergs Arch Pharmacol 1998 Aug;358(2):212-9 |
| TERMUI |
T000911251 T327681 T000911252 T327677 T462344 T327679 T624019 T327680 T327678 T000911250 T000911249 T327676 |
| TH |
NLM (1998) NLM (2004) NLM (2017) US FDA SRS (2013) FDA SRS (2017) DE USAN (19XX) AU MX FR INN (19XX) UK |
| tui |
T109 T121 |